Aug 13 (Reuters) - Acasti Pharma Inc ACST.V :
* ACASTI PHARMA INC - FINALIZED AND SUBMITTED TRILOGY 2 STATISTICAL ANALYSES PLAN TO FDA ON JULY 31
* ACASTI PHARMA INC - TRILOGY 2 TOPLINE RESULTS EXPECTED ON OR ABOUT AUGUST 31
* ACASTI PHARMA INC - AS OF JUNE 30, 2020, ACASTI HAD CASH AND CASH EQUIVALENTS TOTALING $12.1 MILLION
* ACASTI PHARMA INC - BELIEVES IT IS SUFFICIENTLY FUNDED THROUGH FIRST CALENDAR QUARTER OF 2021